Literature DB >> 29878430

Editorial: chronic hepatitis B combination therapy-emerging success as proof-of-concept for future hepatitis B eradication?

Q M Nhu1,2,3, P J Pockros2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29878430      PMCID： PMC5995130          DOI： 10.1111/apt.14680

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  7 in total

1.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

2.  Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance.

Authors:  K Qiu; B Liu; S-Y Li; H Li; Z-W Chen; A-R Luo; M-L Peng; H Ren; P Hu
Journal:  Aliment Pharmacol Ther       Date:  2018-03-26       Impact factor: 8.171

3.  Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

Authors:  Julie Lucifora; Yuchen Xia; Florian Reisinger; Ke Zhang; Daniela Stadler; Xiaoming Cheng; Martin F Sprinzl; Herwig Koppensteiner; Zuzanna Makowska; Tassilo Volz; Caroline Remouchamps; Wen-Min Chou; Wolfgang E Thasler; Norbert Hüser; David Durantel; T Jake Liang; Carsten Münk; Markus H Heim; Jeffrey L Browning; Emmanuel Dejardin; Maura Dandri; Michael Schindler; Mathias Heikenwalder; Ulrike Protzer
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

4.  Hepatitis B cure: From discovery to regulatory approval.

Authors:  Anna S Lok; Fabien Zoulim; Geoffrey Dusheiko; Marc G Ghany
Journal:  Hepatology       Date:  2017-08-01       Impact factor: 17.425

Review 5.  Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.

Authors:  Hung-Chih Yang; Jia-Horng Kao
Journal:  Emerg Microbes Infect       Date:  2014-09-17       Impact factor: 7.163

Review 6.  Drugs in Development for Hepatitis B.

Authors:  Altaf Dawood; Syed Abdul Basit; Mahendran Jayaraj; Robert G Gish
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

Review 7.  Immunotherapy for Chronic Hepatitis B Virus Infection.

Authors:  Antonio Bertoletti; Nina Le Bert
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.